
Adagene and City of Hope launch Phase 1 trial for new colorectal cancer combo therapy.
Adagene Inc. and City of Hope have started a Phase 1 clinical trial testing a new combination therapy for metastatic colorectal cancer patients resistant to standard treatments. The trial evaluates two experimental drugs, ivonescimab and muzastotug (...





